Zevra targets expanded patient reach with 52 annual MIPLYFFA enrollments while advancing European access
Source: SeekingAlpha
2026-03-09 19:38:35 ET
More on Zevra Therapeutics, Inc.
- Zevra Therapeutics, Inc. (ZVRA) Q4 2025 Earnings Call Transcript
- Zevra Therapeutics, Inc. (ZVRA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Zevra Therapeutics, Inc. (ZVRA) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- Zevra Therapeutics, Inc. Q4 2025 Earnings Preview
- Zevra Therapeutics appoints Justin Renz as CFO
Read the full article on Seeking Alpha
For further details see:
Zevra targets expanded patient reach with 52 annual MIPLYFFA enrollments while advancing European access
Zevra Therapeutics Inc.
NASDAQ: ZVRA
ZVRA Trading
-6.76% G/L:
$10.075 Last:
2,626,935 Volume:
$10.76 Open:
ZVRA Latest News
ZVRA Stock Data
$484,721,776
54,946,394
0.39%
48
N/A
Biotechnology & Life Sciences
Healthcare
US
Celebration
